KLRK1 and neoplasm: IL-2 activation induced the expression of the CD69, NKG2D, and TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) activation markers on NK cells and increased their responsiveness to YAC-1 tumor cells (Figure 2B and data not shown).